General Nutrition Center
Based in PA
🤖
AI Overview
With $401K in lobbying spend across 29 quarterly filings, General Nutrition Center is an active lobbying client. Their lobbying covers 5 issue areas. Active from 2018 to 2025.
$401K
Total Spend
8
Years Active
1
Firms Hired
3
Lobbyists Deployed
5
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $120K |
| 2019 | $120K |
| 2020 | $120K |
| 2021 | $30K |
| 2022 | $11K |
| 2023 | $0 |
| 2024 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Agriculture, Trade, Chemicals, Copyright/Patent
- •Monitor amendments and legislation that may affect dietary supplements. No specific legislation introduced yet.
- •Draft guidance on NDI's.
- •Appropriations issues affecting the supplement industry.
- •Issues related to the Supplemental Nutrition Assistance Program (SNAP) and the Women, Infants and Children Program (WIC).
- •Monitor amendments and legislation that may affect dietary supplements. No specific legislation introduced yet. Draft Guidance on NDI's. Appropriations issues affecting the supplement industry.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.